Cormorant Asset Management LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:02 pm Sale | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management LP | 0 0.000% | -1,952,032 (Position Closed) | Filing |
| 2023-02-14 3:15 pm Sale | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management LP | 1,952,032 8.380% | -31,136 (-1.57%) | Filing |
| 2021-07-09 4:06 pm Purchase | 2021-06-29 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management LP | 1,983,168 8.690% | 1,983,168 (New Position) | Filing |